No takes yet. Share an insight, caveat, or question.
Review highlights genetic mutations and emerging therapies in arrhythmogenic cardiomyopathy, suggesting improved disease management strategies.
Popa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: